Results 71 to 80 of about 1,312 (178)
ABSTRACT Generalised Bullous Fixed Drug Eruption (GBFDE) is a subtype of Fixed Drug Eruption (FDE) characterised by the development of generalised blisters on the background of dusky macules. There is no gold standard treatment, but the condition is conventionally managed with supportive care, topical and oral steroids and occasionally ciclosporin.
Olga Pawlik +2 more
wiley +1 more source
Drug‐Induced Periocular and Ocular Surface Disorders: An EAACI Position Paper
ABSTRACT Various systemic and topical medications can induce ocular and periocular cutaneous adverse effects (AEs), ranging from mild to severe. These AEs may lead to ocular surface (OS) damage and, in some cases, life‐threatening complications. Drug‐induced ocular adverse reactions are generally classified into two primary categories: toxic reactions ...
Andrea Leonardi +16 more
wiley +1 more source
ABSTRACT Methotrexate (MTX) is a conventional systemic therapy widely used to treat chronic plaque‐type psoriasis, a chronic inflammatory skin disease that significantly impacts patients' quality of life. MTX can be administered orally or subcutaneously. Over the past decades, the use of subcutaneous versus oral MTX has been a subject of ongoing debate
Manuelle Viguier +7 more
wiley +1 more source
Systemic provocation in doxycycline induced fixed drug eruption: a case report [PDF]
Fixed drug eruption (FDE) is recurrent lesions that upon repeated uptake of causative drug, always appears at the same skin and mucosal site. Determination of causal relationship in drug allergy is very important.
Hananti, Rosmarini Estri Sih +2 more
core +2 more sources
Generalized bullous fixed drug eruption imitating toxic epidermal necrolysis: a case report and literature review [PDF]
Fixed drug eruption (FDE) is defined as sharply demarcated erythematous patches or plaques that occur secondary to systemic exposure to a causative medication. Eruptions are deemed "fixed" because upon repeated exposure they recur at previously affected sites.
Mitre, Victoria +3 more
openaire +4 more sources
ABSTRACT Background The increasing use of Magnetic Resonance Imaging (MRI) has led to a rise in the administration of gadolinium‐based contrast agents (GBCAs), accompanied by a growing number of reported adverse events (AEs). Objective This review aims to provide an updated overview of hypersensitivity reactions (HSRs) to GBCAs, focusing on diagnostic ...
Francesca Losa +14 more
wiley +1 more source
A Review of Hand Eczema Subtypes: Clinical Features, Biomarkers and Treatment Strategies
ABSTRACT Hand eczema is a common dermatological condition that significantly impairs quality of life. The classification of hand eczema has been considered an essential step for its management. The diagnosis of hand eczema relies on the aetiological and clinical features of hand lesions, a process complicated by the heterogeneous presentations and the ...
David Pesqué +5 more
wiley +1 more source
Background – Canine pyoderma is one of the most common presentations in small animal practice, frequently leading to antimicrobial prescribing. Objectives – To provide clinicians with antimicrobial treatment guidelines for staphylococcal pyoderma, including those involving meticillin‐resistant staphylococci.
Anette Loeffler +9 more
wiley +1 more source
NSAIDS induced cutaneous adverse drug reaction – a case series [PDF]
Nonsteroidal anti-inflammatory drugs (NSAIDs) are common cause of cutaneous adverse reactions (CADR’s). Though there are fairly high numbers of agents which commonly cause CADR, NSAID’s holds no exception.
Begum, Sabnam Ara +5 more
core +1 more source

